| Literature DB >> 29353302 |
Clara Oliveras1, Adriana Fortea, Laura Espinosa, Pablo Barrio, Anna Lligoña, Mercè Balcells-Olivero.
Abstract
Benzodiazepines (BZDs) are central nervous system (CNS) depressants which are widely used to treat insomnia and anxiety, despite having long-term adverse side effects. (Fortea González, Oriolo, Balcells Oliveró, Sánchez Del Valle & Castellvi, 2017). As with alcohol, continued use can lead to tolerance and dependence phenomena. Discontinuation in such cases can produce abstinence symptoms such as tremors, anxiety, seizures and, occasionally, death (Brett y Murnion, 2015).Entities:
Mesh:
Substances:
Year: 2018 PMID: 29353302 DOI: 10.20882/adicciones.1058
Source DB: PubMed Journal: Adicciones ISSN: 0214-4840 Impact factor: 2.979